A business in context

ARCT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-23 · 0001193805-26-001277 · Items 7.01,9.01

  2. 8-K · Current report

    Report date 2026-08-25 · 0001193805-26-001130 · Items 7.01,9.01

  3. 8-K · Current report

    Report date 2026-08-06 · 0001193805-26-001039 · Items 2.02,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338090

  5. 8-K · Current report

    Report date 2026-06-26 · 0001193805-26-000910 · Items 1.01,7.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000829

  7. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000828

  8. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000827

  9. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000826

  10. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000825

  11. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000824

  12. 4 · Ownership change

    Report date 2026-06-05 · 0001193805-26-000823

  13. 8-K · Current report

    Report date 2026-06-05 · 0001193805-26-000770 · Items 5.07

  14. 4 · Ownership change

    Report date 2026-05-01 · 0001193805-26-000578

  15. 8-K · Current report

    Report date 2026-05-01 · 0001193805-26-000573 · Items 2.02,5.02,7.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211943

  17. DEF 14A · Proxy statement

    Report date 2026-06-05 · 0001193805-26-000507

  18. 8-K · Current report

    Report date 2026-03-03 · 0001193805-26-000214 · Items 2.02,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-088391

  20. 8-K · Current report

    Report date 2025-12-11 · 0001193805-25-001734 · Items 5.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-275758

  22. 8-K · Current report

    Report date 2025-11-10 · 0001193805-25-001555 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-10-22 · 0001193805-25-001499 · Items 7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-09-26 · 0001193805-25-001368 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-08-29 · 0001193805-25-001247 · Items 7.01,9.01

  26. 8-K · Current report

    Report date 2025-08-11 · 0001193805-25-001175 · Items 2.02,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106560

  28. 8-K · Current report

    Report date 2025-06-30 · 0001193805-25-000946 · Items 7.01,9.01

  29. 8-K · Current report

    Report date 2025-06-06 · 0001193805-25-000820 · Items 5.07

  30. 8-K · Current report

    Report date 2025-05-12 · 0001193805-25-000630 · Items 2.02,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069210

  32. DEF 14A · Proxy statement

    Report date 2025-06-06 · 0001193805-25-000561

  33. 8-K · Current report

    Report date 2025-03-06 · 0001193805-25-000275 · Items 2.02,9.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-034787

  35. SC 13G · Ownership disclosure

    0001140361-24-045812

  36. 8-K · Current report

    Report date 2024-11-07 · 0001193805-24-001318 · Items 2.02,9.01

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-123469

  38. SC 13G · Ownership disclosure

    0001214659-24-018425

  39. 8-K · Current report

    Report date 2024-08-13 · 0001193805-24-001023 · Items 7.01,9.01

  40. 8-K · Current report

    Report date 2024-08-05 · 0001193805-24-000990 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001768224Arcturus Therapeutics Holdings Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$152.31M$163.60M
    2023-12-31$166.80M$184.44M
    2022-12-31$206.00M$237.13M
    2021-12-31$12.36M$15.37M
    2020-12-31$9.54M$12.42M
    2019-12-31$20.79M$27.40M
    2018-12-31$15.75M$21.14M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗